AI assistant
Sending…
Shattuck Labs, Inc. — Director's Dealing 2021
Aug 11, 2021
34607_dirs_2021-08-11_648b271a-df26-4b54-8d63-759f94857c46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Shattuck Labs, Inc. (STTK)
CIK: 0001680367
Period of Report: 2021-08-10
Reporting Person: Pandite Arundathy N. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock | M | 4259 | $0.01 | Acquired | 106166 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Stock Option (Right to Buy) | $0.01 | M | 4259 | Disposed | 2027-12-21 | Common Stock (4259) | Direct |
Footnotes
F1: This option represented a right to purchase a total of 5,863 shares of the Issuer's common stock and has vested in full.
More from Shattuck Labs, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27